Immunohistochemical and histopathological validation of 18 F-PSMA-1007 PET/CT for intraprostatic cancerous lesions.
Joris G HeetmanRick HermsenLeonie ExterkateHeidi V N Küsters-VandeveldeLenneke J M BrouwerDiederik M SomfordRoderick C N van den BerghJean-Paul A van BastenPublished in: The Prostate (2023)
F-PSMA-1007 PET/CT SUVmax is correlated with the ISUP GG and IRS, and thereby could be a tool to characterize intraprostatic PCa lesions.